References
1. Chadwick J, Mann WN. The Medical Works of Hippocrates: a New Translation from the Original Greek Made Especially for English Readers. Oxford: Blackwell Scientific Publications, 1950: 153.
2. Betts EK, Downes JJ. Anesthetic considerations in newborn surgery. Seminars in Anesthesiology 1984; 3: 59–74.
3. Davidson A, Soriano S. Does anaesthesia harm the developing brain: evidence or speculation? Paediatr Anaesth 2004; 14: 199–200.
4. Walker SM. Pain in children: recent advances and ongoing challenges. Br J Anaesth 2008; 101: 101–10.
5. Anand KJ, Sippell WG, Aynsley-Green A. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet 1987; 1: 62–6.
6. Wolf AR. Pacifiers, passive behaviour and pain. Lancet 1992; 339: 275–6.
7. Anand KJ, Hansen DD, Hickey PR. Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology 1990; 73: 661–70.
8. Anderson BJ, van Lingen RA, Hansen TG, Lin YC, Holford NH. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis. Anesthesiology 2002; 96: 1336–45.
9. Carlos MA, Babyn PS, Marcon MA, Moore AM. Changes in gastric emptying in early postnatal life. J Pediatr 1997; 130: 931–7.
10. Agunod M, Yamaguchi N, Lopez R, Luhby AL, Glass GB. Correlative study of hydrochloric acid, pepsin, and intrinsic factor secretion in newborns and infants. Am J Dig Dis 1969; 14: 400–14.
11. Huang NN, High RH. Comparison of serum levels following the administration of oral and parenteral preparations of penicillin to infants and children of various age groups. J Pediatr 1953; 42: 657–8.
12. Taddio A, Shennan AT, Stevens B, Leeder JS, Koren G. Safety of lidocaine-prilocaine cream in the treatment of preterm neonates. J Pediatr 1995; 127: 1002–5.
13. Taddio A, Stevens B, Craig K, et al. Efficacy and safety of lidocaine-prilocaine cream for pain during circumcision. N Engl J Med 1997; 336: 1197–201.
14. Carry MR, Ringel SP, Starcevich JM. Distribution of capillaries in normal and diseased human skeletal muscle. Muscle Nerve 1986; 9: 445–54.
15. Salanitre E, Rackow H. The pulmonary exchange of nitrous oxide and halothane in infants and children. Anesthesiology 1969; 30: 388–94.
16. Lerman J. Pharmacology of inhalational anaesthetics in infants and children. Paediatr Anaesth 1992; 2: 191–203.
17. Lerman J, Schmitt Bantel BI, et al. Effect of age on the solubility of volatile anesthetics in human tissues. Anesthesiology 1986; 65: 307–11.
18. Malviya S, Lerman J. The blood/gas solubilities of sevoflurane, isoflurane, halothane, and serum constituent concentrations in neonates and adults. Anesthesiology 1990; 72: 793–6.
19. Friis-Hansen B. Body water compartments in children: changes during growth and related changes in body composition. Pediatrics 1961; 28: 169–81.
20. Anderson BJ, McKee AD, Holford NH. Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients. Clin Pharmacokinet 1997; 33: 313–27.
21. Luz G, Innerhofer P, Bachmann B, et al. Bupivacaine plasma concentrations during continuous epidural anesthesia in infants and children. Anesth Analg 1996; 82: 231–4.
22. Booker PD, Taylor C, Saba G. Perioperative changes in alpha 1-acid glycoprotein concentrations in infants undergoing major surgery. Br J Anaesth 1996; 76: 365–8.
23. Kearns GL, Reed MD. Clinical pharmacokinetics in infants and children: a reappraisal. Clin Pharmacokinet 1989; 17: 29–67.
24. Tsai CE, Daood MJ, Lane RH, et al. P-glycoprotein expression in mouse brain increases with maturation. Biol Neonate 2002; 81: 58–64.
25. Painter MJ, Pippenger C, Wasterlain C, et al. Phenobarbital and phenytoin in neonatal seizures: metabolism and tissue distribution. Neurology 1981; 31: 1107–12.
26. Park MK, Ludden T, Arom KV, Rogers J, Oswalt JD. Myocardial vs serum digoxin concentrations in infants and adults. Am J Dis Child 1982; 136: 418–20.
27. Gorodischer R, Jusko WJ, Yaffe SJ. Tissue and erythrocyte distribution of digoxin in infants. Clin Pharmacol Ther 1976; 19: 256–63.
28. Way WL, Costley EC, Way EL. Respiratory sensitivity of the newborn infant to meperidine and morphine. Clin Pharmacol Ther 1965; 6: 454–61.
29. Hertzka RE, Gauntlett IS, Fisher DM, Spellman MJ. Fentanyl-induced ventilatory depression: effects of age. Anesthesiology 1989; 70: 213–18.
30. Bouwmeester NJ, Anderson BJ, Tibboel D, Holford NH. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. Br J Anaesth 2004; 92: 208–17.
31. Lynn AM, Nespeca MK, Opheim KE, Slattery JT. Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesth Analg 1993; 77: 695–701.
32. Pariente-Khayat A, Rey E, Gendrel D, et al. Isoniazid acetylation metabolic ratio during maturation in children. Clin Pharmacol Ther 1997; 62: 377–83.
33. Sweeney BP, Bromilow J. Liver enzyme induction and inhibition: implications for anaesthesia. Anaesthesia 2006; 61: 159–77.
34. Hines RN, McCarver DG. The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 2002; 300: 355–60.
35. Koukouritaki SB, Manro JR, Marsh SA, et al. Developmental expression of human hepatic CYP2C9 and CYP2C19. J Pharmacol Exp Ther 2004; 308: 965–74.
36. Berde C. Convulsions associated with pediatric regional anesthesia. Anesth Analg 1992; 75: 164–6.
37. Palmer GM, Atkins M, Anderson BJ, et al. I.V. acetaminophen pharmacokinetics in neonates after multiple doses. Br J Anaesth 2008; 101: 523–30
38. de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin Pharmacokinet 1999; 36: 439–52.
39. Pacifici GM, Sawe J, Kager L, Rane A. Morphine glucuronidation in human fetal and adult liver. Eur J Clin Pharmacol 1982; 22: 553–8.
40. Anand KJ, Anderson BJ, Holford NH, et al. Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial. Br J Anaesth 2008; 101: 680–9.
41. Potts AL, Warman GR, Anderson BJ. Dexmedetomidine disposition in children: a population analysis. Paediatr Anaesth 2008; 18: 722–30.
42. Rhodin MM, Anderson BJ, Peters AM, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 2009; 24: 67–76.
43. Alam SN, Roberts RJ, Fischer LJ. Age-related differences in salicylamide and acetaminophen conjugation in man. J Pediatr 1977; 90: 130–5.
44. Arant BS. Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr 1978; 92: 705–12.
45. Langhendries JP, Battisti O, Bertrand JM, et al. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit. Biol Neonate 1998; 74: 351–62.
46. Besunder JB, Reed MD, Blumer JL. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I). Clin Pharmacokinet 1988; 14: 189–216.
47. Anderson BJ, Pons G, Autret-Leca E, Allegaert K, Boccard E. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. Paediatr Anaesth 2005; 15: 282–92.
48. Zsigmond EK, Downs JR. Plasma cholinesterase activity in newborns and infants. Can Anaesth Soc J 1971; 18: 278–85.
49. Freye E. Development of sensory information processing: the ontogenesis of opioid binding sites in nociceptive afferents and their significance in the clinical setting. Acta Anaesthesiol Scand Suppl 1996; 109: 98–101.
50. Fisher DM, O'Keeffe C, Stanski DR, et al. Pharmacokinetics and pharmacodynamics of D-tubocurarine in infants, children, and adults. Anesthesiology 1982; 57: 203–8.
51. Meakin G, Morton RH, Wareham AC. Age-dependent variation in response to tubocurarine in the isolated rat diaphragm. Br J Anaesth 1992; 68: 161–3.
52. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367: 607–14.
53. Brooks-Kayal AR, Pritchett DB. Developmental changes in human gamma-aminobutyric acidA receptor subunit composition. Ann Neurol 1993; 34: 687–93.
54. Chugani DC, Muzik O, Juhasz C, et al. Postnatal maturation of human GABAA receptors measured with positron emission tomography. Ann Neurol 2001; 49: 618–26.
55. LeDez KM, Lerman J. The minimum alveolar concentration (MAC) of isoflurane in preterm neonates. Anesthesiology 1987; 67: 301–7.
56. Marshall J, Rodarte A, Blumer J, et al. Pediatric pharmacodynamics of midazolam oral syrup. Pediatric Pharmacology Research Unit Network. J Clin Pharmacol 2000; 40: 578–89.
57. Takahashi H, Ishikawa S, Nomoto S, et al. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children. Clin Pharmacol Ther 2000; 68: 541–55.
58. Marshall JD, Kearns GL. Developmental pharmacodynamics of cyclosporine. Clin Pharmacol Ther 1999; 66: 66–75.
59. Williams DG, Hatch DJ, Howard RF. Codeine phosphate in paediatric medicine. Br J Anaesth 2001; 86: 413–21.
60. Allegaert K, van den Anker JN, de Hoon JN, et al. Covariates of tramadol disposition in the first months of life. Br J Anaesth 2008; 100: 525–32.
61. Anderson BJ, Meakin GH. Scaling for size: some implications for paediatric anaesthesia dosing. Paediatr Anaesth 2002; 12: 205–19.
62. Holford NHG. A size standard for pharmacokinetics. Clin Pharmacokinet 1996; 30: 329–32.
63. West GB, Brown JH, Enquist BJ. A general model for the origin of allometric scaling laws in biology. Science 1997; 276: 122–6.
64. Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008; 48: 303–32.
65. Tod M, Jullien V, Pons G. Facilitation of drug evaluation in children by population methods and modelling. Clin Pharmacokinet 2008; 47: 231–43.
